{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T12:59:44Z","timestamp":1792241984532,"version":"4.4.0"},"reference-count":40,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,2,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Epidemiologically, high-density lipoprotein (HDL) cholesterol levels associate inversely with risk of ischemic cardiovascular disease. Whether this is a causal relation is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>We studied 10,281 participants in the Copenhagen City Heart Study (CCHS) and 50,523 participants in the Copenhagen General Population Study (CGPS), of which 991 and 1,693 participants, respectively, had developed myocardial infarction (MI) by August 2010. Participants in the CCHS were genotyped for all six variants identified by resequencing lecithin-cholesterol acyltransferase in 380 individuals. One variant, S208T (rs4986970, allele frequency 4%), associated with HDL cholesterol levels in both the CCHS and the CGPS was used to study causality of HDL cholesterol using instrumental variable analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Epidemiologically, in the CCHS, a 13% (0.21 mmol\/liter) decrease in plasma HDL cholesterol levels was associated with an 18% increase in risk of MI. S208T associated with a 13% (0.21 mmol\/liter) decrease in HDL cholesterol levels but not with increased risk of MI or other ischemic end points. The causal odds ratio for MI for a 50% reduction in plasma HDL cholesterol due to S208T genotype in both studies combined was 0.49 (0.11\u20132.16), whereas the hazard ratio for MI for a 50% reduction in plasma HDL cholesterol in the CCHS was 2.11 (1.70\u20132.62) (Pcomparison = 0.03).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Low plasma HDL cholesterol levels robustly associated with increased risk of MI but genetically decreased HDL cholesterol did not. This may suggest that low HDL cholesterol levels per se do not cause MI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/jc.2011-1846","type":"journal-article","created":{"date-parts":[[2011,11,17]],"date-time":"2011-11-17T06:37:45Z","timestamp":1321511865000},"page":"E248-E256","source":"Crossref","is-referenced-by-count":259,"title":["LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals"],"prefix":"10.1210","volume":"97","author":[{"given":"Christiane L.","family":"Haase","sequence":"first","affiliation":[{"name":"Department of Clinical Biochemistry (C.L.H., A.T.-H., A.A.Q., J.S., R.F.-S.), Rigshospitalet, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry (C.L.H., A.T.-H., A.A.Q., J.S., R.F.-S.), Rigshospitalet, DK-2100 Copenhagen, Denmark"},{"name":"The Copenhagen City Heart Study (A.T.-H., B.G.N.), Bispebjerg Hospital, DK-2100 Copenhagen, Denmark"},{"name":"Department of Clinical Biochemistry (B.G.N.), DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Ali Qayyum","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry (C.L.H., A.T.-H., A.A.Q., J.S., R.F.-S.), Rigshospitalet, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesper","family":"Schou","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry (C.L.H., A.T.-H., A.A.Q., J.S., R.F.-S.), Rigshospitalet, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G.","family":"Nordestgaard","sequence":"additional","affiliation":[{"name":"The Copenhagen City Heart Study (A.T.-H., B.G.N.), Bispebjerg Hospital, DK-2100 Copenhagen, Denmark"},{"name":"Department of Clinical Biochemistry (B.G.N.), DK-2100 Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study (A.T.-H., B.G.N., R.F.-S.), Herlev Hospital, Copenhagen University Hospitals and Faculty of Health Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[{"name":"Department of Clinical Biochemistry (C.L.H., A.T.-H., A.A.Q., J.S., R.F.-S.), Rigshospitalet, DK-2100 Copenhagen, Denmark"},{"name":"The Copenhagen General Population Study (A.T.-H., B.G.N., R.F.-S.), Herlev Hospital, Copenhagen University Hospitals and Faculty of Health Sciences, University of Copenhagen, DK-2100 Copenhagen, Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071618580504100_B1","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease.","volume":"302","author":"Emerging Risk Factors Collaboration","year":"2009","journal-title":"JAMA"},{"key":"2020071618580504100_B2","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1194\/jlr.R001610","article-title":"The HDL hypothesis: does high-density lipoprotein protect from atherosclerosis?","volume":"51","author":"Vergeer","year":"2010","journal-title":"J Lipid Res"},{"key":"2020071618580504100_B3","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1136\/hrt.2007.125401","article-title":"Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.","volume":"94","author":"Hausenloy","year":"2008","journal-title":"Heart"},{"key":"2020071618580504100_B4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1136\/hrt.2007.126326","article-title":"Time to rethink high-density lipoprotein?","volume":"94","author":"Wild","year":"2008","journal-title":"Heart"},{"key":"2020071618580504100_B5","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCULATIONAHA.109.881979","article-title":"Lecithin:cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script.","volume":"120","author":"Rader","year":"2009","journal-title":"Circulation"},{"key":"2020071618580504100_B6","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease.","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"2020071618580504100_B7","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.atherosclerosis.2009.06.005","article-title":"Genetic variation in the ABCA1 gene, HDL cholesterol, and risk of ischemic heart disease in the general population.","volume":"208","author":"Frikke-Schmidt","year":"2010","journal-title":"Atherosclerosis"},{"key":"2020071618580504100_B8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/MOL.0b013e32834477d2","article-title":"Genetic determinants of LDL, lipoprotein(a), triglyceride-rich lipoproteins and HDL: concordance and discordance with cardiovascular disease risk.","volume":"22","author":"Nordestgaard","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"2020071618580504100_B9","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids.","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"2020071618580504100_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u201cMendelian randomization\u201d: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"2020071618580504100_B11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1365-2796.2011.02381.x","article-title":"Mutation in APOA1 predicts increased risk of ischaemic heart disease and total mortality without low HDL cholesterol levels.","volume":"270","author":"Haase","year":"2011","journal-title":"J Intern Med"},{"key":"2020071618580504100_B12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"2020071618580504100_B13","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/eurheartj\/ehl001","article-title":"Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology.","volume":"27","author":"Fox","year":"2006","journal-title":"Eur Heart J"},{"key":"2020071618580504100_B14","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction.","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"key":"2020071618580504100_B15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1161\/CIRCGENETICS.111.959809","article-title":"Copy number variation in glutathione s-transferases M1 and T1 and ischemic vascular disease: four studies and meta-analyses.","volume":"4","author":"N\u00f8rskov","year":"2011","journal-title":"Circ Cardiovasc Genet"},{"key":"2020071618580504100_B16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/oxfordjournals.aje.a010013","article-title":"Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies.","volume":"150","author":"Clarke","year":"1999","journal-title":"Am J Epidemiol"},{"key":"2020071618580504100_B17","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology.","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"2020071618580504100_B18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1136\/bmj.326.7382.219","article-title":"Interaction revisited: the difference between two estimates.","volume":"326","author":"Altman","year":"2003","journal-title":"BMJ"},{"key":"2020071618580504100_B19","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1073\/pnas.83.8.2335","article-title":"Cloning and expression of human lecithin-cholesterol acyltransferase cDNA.","volume":"83","author":"McLean","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071618580504100_B20","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0022-2275(20)33864-5","article-title":"Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter.","volume":"39","author":"Hoppe","year":"1998","journal-title":"J Lipid Res"},{"key":"2020071618580504100_B21","first-page":"2817","article-title":"Lecithin cholesterol acyltransferase deficiency and fish eye disease","volume-title":"The metabolic and molecular bases of inherited disease","author":"Santamarina-Fojo","year":"2001","edition":"8th ed"},{"key":"2020071618580504100_B22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1210\/jc.2008-1342","article-title":"Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease.","volume":"94","author":"Johannsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618580504100_B23","doi-asserted-by":"crossref","first-page":"E500","DOI":"10.1210\/jc.2010-0450","article-title":"Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease.","volume":"95","author":"Haase","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618580504100_B24","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1093\/eurheartj\/ehp145","article-title":"The T111I variant in the endothelial lipase gene and risk of coronary heart disease in three independent populations.","volume":"30","author":"Jensen","year":"2009","journal-title":"Eur Heart J"},{"key":"2020071618580504100_B25","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.2337\/diabetes.51.4.1208","article-title":"A common promoter polymorphism in the hepatic lipase gene (LIPC-480C&gt;T) is associated with an increase in coronary calcification in type 1 diabetes.","volume":"51","author":"Hokanson","year":"2002","journal-title":"Diabetes"},{"key":"2020071618580504100_B26","first-page":"2835","article-title":"Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism","volume-title":"The metabolic and molecular bases of inherited disease","author":"Mahley","year":"2001","edition":"8th ed"},{"key":"2020071618580504100_B27","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1161\/01.CIR.101.24.2777","article-title":"Cardiovascular disease mortality in familial forms of hypertriglyceridemia: a 20-year prospective study.","volume":"101","author":"Austin","year":"2000","journal-title":"Circulation"},{"key":"2020071618580504100_B28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJM198208053070601","article-title":"Increased lipoprotein-remnant formation in chronic renal failure.","volume":"307","author":"Nestel","year":"1982","journal-title":"N Engl J Med"},{"key":"2020071618580504100_B29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0021-9150(87)90130-4","article-title":"Increased cholesterol concentration in intermediate density lipoprotein fraction of normolipidemic non-insulin-dependent diabetics.","volume":"63","author":"Kasama","year":"1987","journal-title":"Atherosclerosis"},{"key":"2020071618580504100_B30","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1161\/01.CIR.96.6.1737","article-title":"Heterozygous lipoprotein lipase deficiency: frequency in the general population, effect on plasma lipid levels, and risk of ischemic heart disease.","volume":"96","author":"Nordestgaard","year":"1997","journal-title":"Circulation"},{"key":"2020071618580504100_B31","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI109956","article-title":"A-I Milano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.","volume":"66","author":"Franceschini","year":"1980","journal-title":"J Clin Invest"},{"key":"2020071618580504100_B32","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/CIRCULATIONAHA.105.540427","article-title":"Compromised LCAT function is associated with increased atherosclerosis.","volume":"112","author":"Hovingh","year":"2005","journal-title":"Circulation"},{"key":"2020071618580504100_B33","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCULATIONAHA.108.848143","article-title":"Functional lecithin: cholesterol acyltransferase is not required for efficient atheroprotection in humans.","volume":"120","author":"Calabresi","year":"2009","journal-title":"Circulation"},{"key":"2020071618580504100_B34","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1126\/science.1099870","article-title":"Multiple rare alleles contribute to low plasma levels of HDL cholesterol.","volume":"305","author":"Cohen","year":"2004","journal-title":"Science"},{"key":"2020071618580504100_B35","doi-asserted-by":"crossref","DOI":"10.1172\/JCI200420361","article-title":"Genetic variation in ABC transporter A1 contributes to HDL cholesterol in the general population","author":"Frikke-Schmidt","year":"2004","journal-title":"J Clin Invest"},{"key":"2020071618580504100_B36","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1172\/JCI118800","article-title":"An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease).","volume":"98","author":"Kuivenhoven","year":"1996","journal-title":"J Clin Invest"},{"key":"2020071618580504100_B37","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1172\/JCI118348","article-title":"A unique genetic and biochemical presentation of fish-eye disease.","volume":"96","author":"Kuivenhoven","year":"1995","journal-title":"J Clin Invest"},{"key":"2020071618580504100_B38","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1161\/01.ATV.16.2.294","article-title":"Two novel molecular defects in the LCAT gene are associated with fish eye disease.","volume":"16","author":"Kuivenhoven","year":"1996","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071618580504100_B39","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.cca.2011.03.011","article-title":"Characterization of antioxidant\/anti-inflammatory properties and apoA-I-containing subpopulations of HDL from family subjects with monogenic low HDL disorders.","volume":"412","author":"Daniil","year":"2011","journal-title":"Clin Chim Acta"},{"key":"2020071618580504100_B40","doi-asserted-by":"crossref","first-page":"16231","DOI":"10.1074\/jbc.272.26.16231","article-title":"Novel function of lecithin-cholesterol acyltransferase.","volume":"272","author":"Goyal","year":"1997","journal-title":"J Biol Chem"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/2\/E248\/10414298\/jcemE248.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/97\/2\/E248\/10414298\/jcemE248.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T18:06:59Z","timestamp":1639678019000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/97\/2\/E248\/2836563"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,1]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2011-1846","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,1]]}}}